Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
NYBSP-4 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020 1 0
NYBSP-1 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020 1 0
NYBSP-2 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020 1 0
Chlorpromazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Aripiprazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Thioridazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Tiapride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Trifluoperazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 1 0
Excel (.xslx) CSV (.csv)